BioCentury
ARTICLE | Company News

BASF, Verenium deal

September 30, 2013 7:00 AM UTC

Chemicals company BASF will acquire Verenium for $4 per share in cash in a deal BASF says values Verenium at about $62 million. Verenium develops and commercializes enzymes used in industrial processe...